መነሻ0775 • HKG
add
CK Life Sciences Intl (Holdings) Inc
የቀዳሚ መዝጊያ
$0.51
የቀን ክልል
$0.48 - $0.51
የዓመት ክልል
$0.30 - $0.74
የገበያው አጠቃላይ ዋጋ
4.61 ቢ HKD
አማካይ መጠን
6.86 ሚ
የዋጋ/ገቢ ምጥጥን
-
የትርፍ ክፍያ
-
ዋና ልውውጥ
HKG
የገበያ ዜና
ፋይናንስ
የገቢ መግለጫ
ገቢ
የተጣራ ገቢ
| (HKD) | ጁን 2024info | ከዓመት ዓመት ለውጥ |
|---|---|---|
ገቢ | 1.32 ቢ | 2.20% |
የሥራ ወጪ | 323.51 ሚ | -4.23% |
የተጣራ ገቢ | 500.50 ሺ | -97.29% |
የተጣራ የትርፍ ክልል | 0.04 | -97.20% |
ገቢ በሼር | — | — |
EBITDA | 117.12 ሚ | 36.03% |
ውጤታማ የግብር ተመን | 79.96% | — |
ቀሪ ሒሳብ ሉሆች
አጠቃላይ ንብረቶች
አጠቃላይ ተጠያቂነቶች
| (HKD) | ጁን 2024info | ከዓመት ዓመት ለውጥ |
|---|---|---|
ጥሬ ገንዘብና የአጭር ጊዜ መዋዕለ ንዋይ | 562.09 ሚ | 11.10% |
አጠቃላይ ንብረቶች | 10.89 ቢ | -1.45% |
አጠቃላይ ተጠያቂነቶች | 6.87 ቢ | -0.11% |
አጠቃላይ እሴት | 4.01 ቢ | — |
የሼሮቹ ብዛት | 9.61 ቢ | — |
የገበያ ዋጋ እና የተገለጸ ዋጋ | 1.21 | — |
የእሴቶች ተመላሽ | 1.75% | — |
የካፒታል ተመላሽ | 1.91% | — |
የገንዘብ ፍሰት
የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ
| (HKD) | ጁን 2024info | ከዓመት ዓመት ለውጥ |
|---|---|---|
የተጣራ ገቢ | 500.50 ሺ | -97.29% |
ከክወናዎች የተገኘ ጥሬ ገንዘብ | 72.70 ሚ | 80.63% |
ገንዘብ ከኢንቨስትመንት | -47.88 ሚ | -484.81% |
ገንዘብ ከፋይናንስ | -77.72 ሚ | 41.39% |
የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ | -57.56 ሚ | 42.02% |
ነፃ የገንዘብ ፍሰት | 35.56 ሚ | 91.21% |
ስለ
CK Life Sciences International Inc., or CK Life Sciences, is a subsidiary of CK Hutchison Holdings. It is engaged in research and development, commercialization, marketing and sale of biotechnology products. The chairman is Mr. Victor Li, the elder son of Mr. Li Ka-shing, the chairman of Cheung Kong Holdings.
It was established in 2000 and listed on the Hong Kong Stock Exchange via Growth Enterprise Market in 2002. It was transferred to Main Board of the Hong Kong Stock Exchange in 2008.
CK Life Sciences has operations in Australia, and in 2012 acquired an Australian salt company as part of its expansion into the agricultural sector.
The company divested its Canadian subsidiary WEX Pharmaceuticals to Virios Therapeutics for $100 million in October 2024. Wikipedia
ዋና ሥራ አስፈጻሚ
የተመሰረተው
2000
ድህረገፅ
ሠራተኞች
1,968
